Grupo farmacéutico · Reino Unido
GSK
Un grupo de 117 empresas con 2430 medicamentos en 12 países.
Estructura del grupo
117 empresas en 18 países
Cargando…
Grupo farmacéutico · Reino Unido
Un grupo de 117 empresas con 2430 medicamentos en 12 países.
117 empresas en 18 países
Una cuenta gratuita para las apps de Prognia: Ward para estudiar, Osler para respuestas clínicas con sus fuentes y la red para encontrar a tus colegas.
Prognia forma los grupos a partir de los nombres que publican las autoridades reguladoras y de los vínculos entre empresas; no son una estructura societaria oficial.
Todos los medicamentos de todas las empresas del grupo, primero los vigentes.
1–25 de 2430
| Medicamento | Principio activo | País | Estado | Autorización |
|---|---|---|---|---|
| 3TC300 mg · Tablet | Lamivudine | Canadá | Comercializado | 2003 |
| 3TC150 mg · Tablet | Lamivudine | Canadá | Comercializado | 1995 |
| 3TC10 mg / ml · Solution | Lamivudine | Canadá | Comercializado | 1995 |
| ACTIDIL1.25mg/5ml · Syrup | Triprolidine | Estados Unidos | No comercializado | |
| ACTIDIL2.5mg · Tablet | Triprolidine | Estados Unidos | No comercializado | |
| ACTIFED120mg; 5mg · Capsule, extended release | Pseudoephedrine, Triprolidine | Estados Unidos | No comercializado | |
| ACTIFED W/ CODEINE10MG/5ML; 30MG/5ML; 1.25MG/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · Syrup | Codeine, Pseudoephedrine, Triprolidine | Estados Unidos | No comercializado | |
| ADARTREL 0,25 mg COMPRIMIDOS RECUBIERTOS CON PELICULA0,25 mg · Comprimido recubierto con película | Ropinirole | España | Comercializado | 2006 |
| ADARTREL 0.5 mg COMPRIMIDOS RECUBIERTOS CON PELICULA0,50 mg · Comprimido recubierto con película | Ropinirole | España | Comercializado | 2006 |
| ADARTREL 2 mg COMPRIMIDOS RECUBIERTOS CON PELICULA2 mg · Comprimido recubierto con película | Ropinirole | España | Comercializado | 2006 |
| ADJUPANRIX 3,75 microgramos EMULSION Y SUSPENSION PARA EMULSION INYECTABLE3,75 µg · Emulsion y suspension para emulsion inyectable | Virus gripe a h5n1 inactivado | España | Autorizado | 2013 |
| Adjupanrix, (H5N1) (split virion, inactivated, adjuvanted) GlaxoSmithKline Biologicals, suspensie en emulsie voor emulsie voor injectieSuspensie voor injectie, Emulsie voor injectie | Influenzavaccin a-vietnam-1194-2004 nibrg-14 geinactiveerd, splitvaccin | Países Bajos | Autorizado | 2009 |
| Adjupanrix (previously Pandemic influenza vaccine (H5N1) (split virion, inactivated, adjuvanted) GlaxoSmithKline Biologicals) | Pandemic influenza vaccine | UE (EMA) | Autorizado | 2009 |
| ADVAIR250 mcg / act + 25 mcg / act · Aerosol (Metered-Dose) | Fluticasone, Salmeterol | Canadá | Comercializado | 2001 |
| ADVAIR125 mcg / act + 25 mcg / act · Aerosol (Metered-Dose) | Fluticasone, Salmeterol | Canadá | Comercializado | 2001 |
| ADVAIR 100 DISKUS100 mcg / act + 50 mcg / act · Powder | Fluticasone, Salmeterol | Canadá | Comercializado | 1999 |
| ADVAIR 250 DISKUS250 mcg / act + 50 mcg / act · Powder | Fluticasone, Salmeterol | Canadá | Comercializado | 1999 |
| ADVAIR 500 DISKUS500 mcg / act + 50 mcg / act · Powder | Fluticasone, Salmeterol | Canadá | Comercializado | 1999 |
| ADVAIR DISKUS 100/500.1mg/inh; 0.05mg base/inh · Powder | Fluticasone, Salmeterol | Estados Unidos | Comercializado | 2000 |
| ADVAIR DISKUS 250/500.25mg/inh; 0.05mg base/inh · Powder | Fluticasone, Salmeterol | Estados Unidos | Comercializado | 2000 |
| ADVAIR DISKUS 500/500.5mg/inh; 0.05mg base/inh · Powder | Fluticasone, Salmeterol | Estados Unidos | Comercializado | 2000 |
| ADVAIR HFA0.045mg/inh; 0.021mg base/inh | 0.115mg/inh; 0.021mg base/inh | 0.23mg/inh; 0.021mg base/inh · Aerosol, metered | Fluticasone, Salmeterol | Estados Unidos | Comercializado | 2006 |
| AEROLIN | Solucao salbutamol, Salbutamol | Brasil | Autorizado | 2005 |
| AEROSPORIN500,000 units base/vial · Injectable | Polymyxin b | Estados Unidos | No comercializado | 1980 |
| AGENERASE15MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · Solution | Amprenavir | Estados Unidos | No comercializado | 1999 |
Dónde es titular o fabricante de medicamentos, y cuántos están vigentes.
| País | Medicamentos | Vigentes | Anteriores | Empresas |
|---|---|---|---|---|
| Canadá | 701 | 113 | 588 | EmpresasTodos los medicamentos |
| España | 346 | 301 | 45 | EmpresasTodos los medicamentos |
| Brasil | 306 | 84 | 222 | EmpresasTodos los medicamentos |
| Estados Unidos | 237 | 232 | 5 | EmpresasTodos los medicamentos |
| Arabia Saudí | 207 | 207 | 0 | EmpresasTodos los medicamentos |
| Países Bajos | 185 | 185 | 0 | EmpresasTodos los medicamentos |
| Rumanía | 133 | 0 | 133 | EmpresasTodos los medicamentos |
| Singapur | 113 | 113 | 0 | EmpresasTodos los medicamentos |
| Italia | 88 | 88 | 0 | EmpresasTodos los medicamentos |
| Unión Europea (EMA) | 74 | 45 | 29 | EmpresasTodos los medicamentos |
| Croacia | 38 | 38 | 0 | EmpresasTodos los medicamentos |
| Argentina | 2 | 0 | 2 | EmpresasTodos los medicamentos |
También en los registros de Francia, Reino Unido, Serbia
Los grupos ATC a los que pertenecen la mayoría de sus medicamentos, de mayor a menor.
Los principios activos presentes en la mayoría de sus medicamentos.
Cómo lo escriben los registros, normalizado: sin forma jurídica, tildes ni mayúsculas.
Recopilado por Prognia a partir de los registros públicos de medicamentos y empresas que aparecen abajo. No se usan logotipos.
Prognia forma los grupos a partir de los nombres que publican las autoridades reguladoras y de los vínculos entre empresas; no son una estructura societaria oficial.
Source: European Medicines Agency (EPAR data).
Licencia: EMA reuse policy (source acknowledgement required)
Fuente de la información: AEMPS (CIMA).
Licencia: AEMPS open data reuse with attribution
Source: U.S. FDA, Drugs@FDA / openFDA. FDA does not endorse this site.
Licencia: Public domain (U.S. Government work)
Source: BDPM (ANSM, HAS, UNCAM).
Licencia: Licence Ouverte v1.0
Ministerio de Salud / ANMAT, historical VNM changes, Actualizaciones del Vademecun Nacional de Medicamentos (VNM) - julio 2018, https://datos.salud.gob.ar/dataset/vademecun-nacional-de-medicamentos-vnm, CC BY 4.0, acquired 2026-10-09; structured factual adaptation.
Licencia: Creative Commons Attribution
ANVISA / CMED, consumer price table; embedded source date 2026-07-21 and retrieval date
Licencia: Other (Public Domain)
Anvisa published factual open-data CSV https://dados.anvisa.gov.br/dados/CONSULTAS/PRODUTOS/TA_CONSULTA_MEDICAMENTOS.CSV, HTTP version Mon, 12 Oct 2026 11:45:25 GMT; acquired 12 October 2026; original source states and timestamps retained.
Licencia: Brazil federal factual open data, consolidated Decreto 8777/2016 article 4; attribution and third-party exceptions
Anvisa, official medicine/API manufacturer factual export, HTTP source version Fri, 09 Oct 2026 08:21:54 GMT, acquired 2026-10-09; exact unmodified native identifiers and fields preserved.
Licencia: Brazil federal factual open-data reuse; Decreto 8777/2016 consolidated article 4 and third-party exceptions
Health Canada, Drug Product Database, company API, entire response observed 2026-10-10T15:12:05.508784+00:00; native facts projected by Prognia.
Licencia: Open Government Licence Canada
Health Canada, Drug Product Database, drugproduct API, entire response observed 2026-10-10T15:12:07.336870+00:00; native facts projected by Prognia.
Licencia: Open Government Licence Canada
Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA presentaciones, acquired 11 October 2026 UTC; each source response/update date retained.
Licencia: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required
Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA medicamentos, acquired 11 October 2026 UTC; each source response/update date retained.
Licencia: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required
BDPM / ANSM, HAS and UNCAM; original URLs and each update date retained
Licencia: BDPM exact Licence Ouverte v1.0 (October 2011)
INSEE (www.insee.fr), via DINUM API Recherche d’entreprises; include original record update date and retrieval date
Licencia: Licence Ouverte / Open Licence
Medicines and Healthcare products Regulatory Agency (MHRA), GOV.UK; Category 1 list; publication updated 25 August 2026; acquired 2026-10-15T08:18:47.757811+00:00; original workbook cells and factual authorization/holder projections adapted under Open Government Licence v3.0.
Licencia: Open Government Licence v3.0; exact Crown copyright 2026 publication grant
Medicines and Healthcare products Regulatory Agency (MHRA), GOV.UK; Category 2 list; publication updated 25 August 2026; acquired 2026-10-15T08:18:48.423930+00:00; original workbook cells and factual authorization/holder projections adapted under Open Government Licence v3.0.
Licencia: Open Government Licence v3.0; exact Crown copyright 2026 publication grant
Medicines and Healthcare products Regulatory Agency (MHRA), GOV.UK; October 2026 register, published 7 October 2026; https://assets.publishing.service.gov.uk/media/6ac660fdec9d3aba1e0139d9/MS_Register_-_October_2026.csv; acquired 2026-10-13T22:59:02.704630+00:00; CSV-to-role/site projection is an adaptation under Open Government Licence v3.0.
Licencia: Open Government Licence v3.0; Crown copyright MHRA factual register
Medicines and Healthcare products Regulatory Agency (MHRA), GOV.UK; October 2026 published list; https://assets.publishing.service.gov.uk/media/6ac65f44e8ef5609e7c932fe/List_of_Terminated__Cancelled_and_Revoked_Licences_-_October_2026.csv; acquired 2026-10-14T16:17:19.029217+00:00; CSV-to-licence-event projections are adaptations under OGL v3.0.
Licencia: Open Government Licence v3.0; Crown copyright MHRA published licence history
GLEIF; exact source URLs/locators, version status and retrieval dates. Normalized by Prognia; no official endorsement.
Licencia: CC0
HALMED, Baza lijekova, source export 08.10.2026., acquired 2026-10-08; factual structured adaptation; Otvorena dozvola RH, NN 67/2017.
Licencia: Otvorena dozvola RH
Agenzia Italiana del Farmaco (AIFA); https://www.aifa.gov.it/documents/20142/847386/OFFICINE_API_GIUGNO_2025.csv; HTTP Last-Modified Tue, 08 Jul 2025 11:28:20 GMT; acquired 2026-10-13T17:21:05.497592+00:00; native fields retained, source identifier and role projections are adaptations.
Licencia: CC BY 4.0; AIFA published open-data catalog
Agenzia Italiana del Farmaco (AIFA); https://www.aifa.gov.it/documents/20142/3815901/Classe_A_per_principio_attivo_31-05-2026.csv; HTTP Last-Modified Mon, 28 Sep 2026 08:46:41 GMT; acquired 2026-10-13T17:21:06.055244+00:00; native fields retained, source identifier and role projections are adaptations.
Licencia: CC BY 4.0; AIFA published open-data catalog
Agenzia Italiana del Farmaco (AIFA); https://www.aifa.gov.it/documents/20142/3815901/Classe_H_per_principio_attivo_31-05-2026.csv; HTTP Last-Modified Mon, 28 Sep 2026 08:46:40 GMT; acquired 2026-10-13T17:21:06.034935+00:00; native fields retained, source identifier and role projections are adaptations.
Licencia: CC BY 4.0; AIFA published open-data catalog
Agenzia Italiana del Farmaco (AIFA); https://www.aifa.gov.it/documents/20142/847386/officine_autorizzate_medicinali_30.06.2026.csv; HTTP Last-Modified Wed, 01 Jul 2026 09:37:30 GMT; acquired 2026-10-13T17:21:05.166252+00:00; native fields retained, source identifier and role projections are adaptations.
Licencia: CC BY 4.0; AIFA published open-data catalog
Agenzia Italiana del Farmaco (AIFA); https://drive.aifa.gov.it/farmaci/confezioni_fornitura.csv; HTTP Last-Modified Mon, 12 Oct 2026 23:02:44 GMT; acquired 2026-10-13T17:21:16.224007+00:00; native fields retained, source identifier and role projections are adaptations.
Licencia: CC BY 4.0; AIFA published open-data catalog
Ministero della Salute, Italy; https://www.dati.salute.gov.it/it/dataset/distributori-di-farmaci/; original CSV snapshot 15 October 2026, acquired 2026-10-15T13:26:43.659718+00:00; adapted factual fields under IODL2. Coordinates: © OpenStreetMap contributors, separate rights gate.
Licencia: Italian Open Data Licence v2.0, exact dataset-catalog assignment; coordinate fields separately attributed to OpenStreetMap
Ministero della Salute, Distributori di farmaci, source file13Oct2026. https://www.dati.salute.gov.it/it/dataset/distributori-di-farmaci/; IODL2.0 https://www.dati.gov.it/content/italian-open-data-license-v20. Original URLs/locators and retrieval timestamps; selected/normalized by Prognia; no government endorsement.
Licencia: Italian Open Data Licence
State Enterprise Centre of Registers / Valstybės įmonė Registrų centras; source dataset/resource URL, exact original code/UUID/revision, original CSV ordinal, retrieval time; CC BY 4.0 https://creativecommons.org/licenses/by/4.0/ ; selected field normalization by Prognia.
Licencia: Creative Commons Attribution
College ter Beoordeling van Geneesmiddelen, Geneesmiddeleninformatiebank metadata, source update 07-10-2026; downloaded 08-10-2026; factual adaptation.
Licencia: Conditional noncreative administrative factual metadata; no dataset-wide CC0 claim
Contains data under the Norwegian licence for Open Government data (NLOD) distributed by Brønnøysundregistrene. https://data.norge.no/nlod/en/2.0; original API URLs, retrieval dates and locators. Selected and normalized by Prognia; fractional JSON numbers preserved as labelled exact decimal strings.
Licencia: Norwegian Licence for Open Government Data
Ministerul Sănătății, Catalogul public naţional al preţurilor, 18 iunie 2021, downloaded 2026-10-08 from data.gov.ro; CC BY 4.0; structured factual adaptation, code whitespace trimmed only where explicitly recorded.
Licencia: Creative Commons Attribution 4.0 International (CC BY 4.0)
ALIMS, Registar humanih lekova, source 08.10.2026 02:00, downloaded 2026-10-08, https://data.gov.rs/sr/datasets/lekovi-za-upotrebu-u-khumanoj-meditsini/; structured factual adaptation; Serbian Open Data Licence.
Licencia: Serbian Open Data Licence (sodl)
Saudi Food and Drug Authority (SFDA), foreign human medicine open-data listing, source scope 2023, retrieved 11 October 2026 UTC; exact original file and response modification date retained.
Licencia: Exact SFDA open-data section explicitly offers freely usable named human medicine workbooks; factual-data scope only
Saudi Food and Drug Authority (SFDA), local human medicine open-data listing, source scope 2023, retrieved 11 October 2026 UTC; exact original file and response modification date retained.
Licencia: Exact SFDA open-data section explicitly offers freely usable named human medicine workbooks; factual-data scope only
Contains information from ACRA Information on Corporate Entities, accessed on 8 October 2026 through Data.gov.sg, under Singapore Open Data Licence version 1.0: https://data.gov.sg/open-data-licence. Structured selection and normalisation by Prognia; original UEN, field and retrieval date retained.
Licencia: Singapore Open Data Licence
Contains information from HSA Listing of Registered Therapeutic Products accessed on 8 October 2026 from data.gov.sg, under Singapore Open Data Licence 1.0: https://data.gov.sg/open-data-licence
Licencia: Singapore Open Data Licence
FDA Purple Book, September 2026 release; acquired 2026-10-10T15:29:54.330165+00:00; exact source fields retained with source-key projections.
Licencia: FDA-created structured factual administrative metadata; public-domain policy with third-party exceptions
Informa de un error o solicita la retiradaLas correcciones de la propia empresa son bienvenidas.
Mantenga correctos los medicamentos de GSK en Prognia, vea cómo los consultan los profesionales y responda a lo que preguntan. Una llamada de 20 minutos, en inglés.
Reservar una llamadaGrupos farmacéuticos conocidos, cada uno con todas sus empresas.
Ordenados por su número de medicamentos.